HPV DNA and Cervical wellness
Starting on:
Feb 6, 2025
Ending on:
Feb 6, 2025
Moderator(s):
Dr. Michael Kioko
CMO, PCEA Chogoria Hospital
Venue:
Lenana Restaurant
Max Credits:
3 Points

Provider:
PCEA CHOGORIA HOSPITAL
Claim Points

HPV DNA and Cervical wellness

Starting on:
Feb 6, 2025
Ending on:
Feb 6, 2025
Venue:
Lenana Restaurant

Description

Highly effective and safe vaccines exist to prevent HPV infection and reduce the risk of cervical cancer. However, uptake of the HPV vaccine in LMICs remains low. In 2022, 26 percent of eligible girls in Kenya had received a dose of the HPV vaccine. WHO Response 90% of girls vaccinated with the HPV vaccine by age 15. 70% of women screened with a high-quality test by ages 35 and 45. 90% of women with cervical disease receiving treatment

Objectives

To create awareness and sensitization of HPV vaccine and emphasizes it's importance in prevention of cervical cancer To brainstorm on the best available strategies to be at per with the WHO response

Presenters

  1. Miss Janine Law
    Consultant for International Business Operations
    Pathology Network

  2. Mr. Robert Karanja
    Co-founder of Villgro Village and part of Ayana Project
    Villgro Village and Ayana Network

Search For CPD Activity